Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · Real-Time Price · USD
12.25
+0.03 (0.20%)
Nov 21, 2024, 2:14 PM EST - Market open
Avid Bioservices Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Avid Bioservices stock have an average target of 13.63, with a low estimate of 12 and a high estimate of 16. The average target predicts an increase of 11.31% from the current stock price of 12.25.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CDMO stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 3 | 3 | 3 | 3 | 3 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Buy → Hold Downgrades $12 → $13 | Buy → Hold | Downgrades | $12 → $13 | +2.08% | Nov 7, 2024 |
William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 7, 2024 |
RBC Capital | RBC Capital | Buy Maintains $8 → $12 | Buy | Maintains | $8 → $12 | -2.00% | Sep 10, 2024 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $12 | Buy | Reiterates | $12 | -2.00% | Sep 10, 2024 |
William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 10, 2024 |
Financial Forecast
Revenue This Year
166.93M
from 139.91M
Increased by 19.31%
Revenue Next Year
202.22M
from 166.93M
Increased by 21.14%
EPS This Year
-0.30
from -2.23
EPS Next Year
-0.07
from -0.30
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 172.3M | 236.3M | 253.1M | ||
Avg | 166.9M | 202.2M | 237.0M | ||
Low | 159.5M | 180.9M | 218.2M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 23.2% | 41.5% | 25.1% | ||
Avg | 19.3% | 21.1% | 17.2% | ||
Low | 14.0% | 8.4% | 7.9% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.26 | 0.12 | 0.15 |
Avg | -0.30 | -0.07 | 0.14 |
Low | -0.34 | -0.21 | 0.14 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.